Neoadjuvant Nivolumab Aids In Long Term Lung Cancer Survival
Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had...
Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had...
It has come to light that the federal health agencies have gone on to select three new models so as...
Biopharma companies as well as policymakers know the significance of assessing medical and drug products across a broad range of...
As per a market report by Reportlinker, the worldwide highly potent active pharmaceutical ingredient- HPAPI sector is anticipated to breach...
Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of...
The post-pandemic future of healthcare has compelled one to re-evaluate the supply chain from end-to-end. Be it new technologies, shortened...
In 2023, there are going to be numerous factors that will influence the life science sector, in turn forcing leaders...
The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes...
University of Bonn researchers have come across a new bacterial compound that may very well impede the replication of the...
Scientists have shown that a recently developed two-chamber setup (TCS) for containment investigations that consists of an emission chamber as...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.